Dr. Ryan Sullivan, MD
Claim this profileMassachusetts General Hospital
Expert in Melanoma
Studies Solid Tumors
21 reported clinical trials
34 drugs studied
About Ryan Sullivan, MD
Education:
- Earned an MD (Doctor of Medicine) degree.
Experience:
- Serves as an Associate Professor of Medicine at Harvard Medical School.
- Works as a Physician Investigator at the Cancer Center, Mass General Research Institute.
- Focuses on research in novel molecular therapeutic agents for malignant melanoma, including the translation of preclinical findings into early-stage clinical trials and the development of predictive biomarkers for treatments.
Area of expertise
1Melanoma
Global LeaderStage IV
Stage III
BRAF positive
2Solid Tumors
Stage IV
Stage III
BRAF
Affiliated Hospitals
Clinical Trials Ryan Sullivan, MD is currently running
STK-012 + Pembrolizumab
for Cancer
This trial is testing a new drug called STK-012 alone and with another medication in patients with advanced solid tumors that haven't responded to usual treatments. The aim is to find the right dose and see how well it works.
Recruiting1 award Phase 13 criteria
mRNA Vaccine + Immunotherapy
for Melanoma
This trial is testing if a combination of a personalized cancer vaccine (mRNA-4157) and an immune-boosting medication (pembrolizumab) can better prevent melanoma from returning in patients who have had their tumors surgically removed. Pembrolizumab has been shown to help prevent the return and spread of melanoma in patients who have had their tumors surgically removed.
Recruiting1 award Phase 26 criteria
More about Ryan Sullivan, MD
Clinical Trial Related3 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Ryan Sullivan, MD has experience with
- Pembrolizumab
- ASTX029
- MRNA-4157
- Infliximab
- CPI-0209
- [68Ga]-NOTA-hGZP
Breakdown of trials Ryan Sullivan, MD has run
Melanoma
Solid Tumors
Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan Sullivan, MD specialize in?
Ryan Sullivan, MD focuses on Melanoma and Solid Tumors. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Ryan Sullivan, MD currently recruiting for clinical trials?
Yes, Ryan Sullivan, MD is currently recruiting for 13 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Ryan Sullivan, MD has studied deeply?
Yes, Ryan Sullivan, MD has studied treatments such as Pembrolizumab, ASTX029, mRNA-4157.
What is the best way to schedule an appointment with Ryan Sullivan, MD?
Apply for one of the trials that Ryan Sullivan, MD is conducting.
What is the office address of Ryan Sullivan, MD?
The office of Ryan Sullivan, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.